OBJECTIVES: Low-dose ionizing radiation from medical imaging has been indirectly linked with subsequent cancer. Computed tomography (CT) is the gold standard for defining pancreatic necrosis. The primary goal was to identify the frequency and effective radiation dose of CT imaging for patients with necrotizing pancreatitis. METHODS: All patients with necrotizing pancreatitis (2003-2007) were retrospectively analyzed for CT-related radiation exposure. RESULTS: Necrosis was identified in 18% (238/1290) of patients with acute pancreatitis (mean age = 53 years; hospital/ICU length of stay = 23/7 days; mortality = 9%). A median of five CTs/patient [interquartile range (IQR) = 4] were performed during a median 2.6-month interval. The average effective dose was 40 mSv per patient (equivalent to 2,000 chest X-rays; 13.2 years of background radiation; one out of 250 increased risk of fatal cancer). The actual effective dose was 63 mSv considering various scanner technologies. CTs were infrequently (20%) followed by direct intervention (199 interventional radiology, 118 operative, 12 endoscopic) (median = 1; IQR = 2). Magnetic resonance imaging did not have a CT-sparing effect. Mean direct hospital costs increased linearly with CT number (R = 0.7). CONCLUSIONS: The effective radiation dose received by patients with necrotizing pancreatitis is significant. Management changes infrequently follow CT imaging. The ubiquitous use of CT in necrotizing pancreatitis raises substantial public health concerns and mandates a careful reassessment of its utility.
OBJECTIVES: Low-dose ionizing radiation from medical imaging has been indirectly linked with subsequent cancer. Computed tomography (CT) is the gold standard for defining pancreatic necrosis. The primary goal was to identify the frequency and effective radiation dose of CT imaging for patients with necrotizing pancreatitis. METHODS: All patients with necrotizing pancreatitis (2003-2007) were retrospectively analyzed for CT-related radiation exposure. RESULTS:Necrosis was identified in 18% (238/1290) of patients with acute pancreatitis (mean age = 53 years; hospital/ICU length of stay = 23/7 days; mortality = 9%). A median of five CTs/patient [interquartile range (IQR) = 4] were performed during a median 2.6-month interval. The average effective dose was 40 mSv per patient (equivalent to 2,000 chest X-rays; 13.2 years of background radiation; one out of 250 increased risk of fatal cancer). The actual effective dose was 63 mSv considering various scanner technologies. CTs were infrequently (20%) followed by direct intervention (199 interventional radiology, 118 operative, 12 endoscopic) (median = 1; IQR = 2). Magnetic resonance imaging did not have a CT-sparing effect. Mean direct hospital costs increased linearly with CT number (R = 0.7). CONCLUSIONS: The effective radiation dose received by patients with necrotizing pancreatitis is significant. Management changes infrequently follow CT imaging. The ubiquitous use of CT in necrotizing pancreatitis raises substantial public health concerns and mandates a careful reassessment of its utility.
Authors: Marilyn J Goske; Kimberly E Applegate; Jennifer Boylan; Priscilla F Butler; Michael J Callahan; Brian D Coley; Shawn Farley; Donald P Frush; Marta Hernanz-Schulman; Diego Jaramillo; Neil D Johnson; Sue C Kaste; Gregory Morrison; Keith J Strauss Journal: J Am Coll Radiol Date: 2008-12 Impact factor: 5.532
Authors: Homer C Tien; Lorraine N Tremblay; Sandro B Rizoli; Jacob Gelberg; Fernando Spencer; Curtis Caldwell; Frederick D Brenneman Journal: J Trauma Date: 2007-01
Authors: Jan J De Waele; Louke Delrue; Eric A Hoste; Martine De Vos; Philippe Duyck; Francis A Colardyn Journal: Pancreas Date: 2007-03 Impact factor: 3.327
Authors: Purvi Y Parikh; Henry A Pitt; Molly Kilbane; Thomas J Howard; Attila Nakeeb; C Max Schmidt; Keith D Lillemoe; Nicholas J Zyromski Journal: J Am Coll Surg Date: 2009-10-17 Impact factor: 6.113
Authors: Peter B Bach; James R Jett; Ugo Pastorino; Melvyn S Tockman; Stephen J Swensen; Colin B Begg Journal: JAMA Date: 2007-03-07 Impact factor: 56.272
Authors: Alexsander K Bressan; Jean-Francois Ouellet; Divine Tanyingoh; Elijah Dixon; Gilaad G Kaplan; Sean C Grondin; Robert P Myers; Rachid Mohamed; Chad G Ball Journal: Can J Surg Date: 2016-06 Impact factor: 2.089
Authors: Chad G Ball; Elijah Dixon; Anthony R MacLean; Gilaad G Kaplan; Lynn Nicholson; Francis R Sutherland Journal: Can J Surg Date: 2014-06 Impact factor: 2.089
Authors: Thomas K Maatman; Mark A Heimberger; Kyle A Lewellen; Alexandra M Roch; Cameron L Colgate; Michael G House; Attila Nakeeb; Eugene P Ceppa; C Max Schmidt; Nicholas J Zyromski Journal: Can J Surg Date: 2020-05-21 Impact factor: 2.089
Authors: Ari Leppäniemi; Matti Tolonen; Antonio Tarasconi; Helmut Segovia-Lohse; Emiliano Gamberini; Andrew W Kirkpatrick; Chad G Ball; Neil Parry; Massimo Sartelli; Daan Wolbrink; Harry van Goor; Gianluca Baiocchi; Luca Ansaloni; Walter Biffl; Federico Coccolini; Salomone Di Saverio; Yoram Kluger; Ernest Moore; Fausto Catena Journal: World J Emerg Surg Date: 2019-06-13 Impact factor: 5.469